Nigeria’s response to the latest Ebola outbreak is being complicated by the absence of a licensed, strain-specific treatment or vaccine, with the Federal Government relying on supportive medical care, laboratory testing and contact tracing to contain the infection.
The Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, disclosed this during an interview with Arise Television on Wednesday, saying the infected patient was receiving medical attention and was stable at the time of the interview.
Pate explained that although researchers were exploring potential vaccines and treatments, no specific product had yet been licensed for use against the Bundibugyo strain responsible for the current outbreak.
“Specific treatment for this variant of Ebola virus, or a specific vaccine, is not yet licensed, approved to be used,” he said, adding that “there are various efforts to try different types of vaccines or molecules to see whether they can bring relief.”
According to the minister, the patient received antibiotics and antiviral medication at different stages of her treatment because doctors initially suspected a viral illness before confirming Ebola.
He said she was receiving supportive care while her immune system responded to the infection, cautioning that her condition could change as the disease progressed.
“I think we’re very fortunate that she is stable at this moment. We hope she continues to remain stable, because things can change when you have an infectious disease that you don’t fully control the course of illness,” Pate said.
The development has heightened attention on Nigeria’s public health preparedness, particularly following confirmation of the country’s first reported case in the current outbreak involving a woman who travelled from Uganda and was admitted to a private hospital in Abuja.
The patient was subsequently diagnosed with the Bundibugyo strain of Ebola, prompting the Nigeria Centre for Disease Control and Prevention to intensify surveillance, contact tracing and infection prevention measures.
Pate said Nigeria’s laboratory infrastructure, healthcare facilities and trained medical personnel had helped identify the infection and provide treatment. He added that public and private health institutions were working with epidemiologists and other public health experts to identify and monitor people who might have been exposed.
“We’ve got laboratory capacity that has all come together to allow the patient to walk through the Nigerian healthcare system, be detected, and be catered for,” he said.
However, the minister stressed that the success of the response would also depend on public cooperation, particularly among people identified as contacts of the infected patient.
“But it goes beyond the public health system; it also requires Nigerians themselves in how we behave, so that those who may have contact with her continue to comply,” he added.
As part of the response, health authorities have been monitoring people potentially exposed to the virus across several states. Reports cited by The PUNCH indicated that 44 contacts had initially been identified, while Anambra and Ogun states were also tracing people considered at risk.
The United States Mission in Nigeria has also issued a health advisory to its citizens following the reported case.
Ebola is a serious infectious disease that spreads primarily through direct contact with the blood or other body fluids of an infected person who has developed symptoms, or through contaminated materials. Symptoms may include fever, severe headache, weakness, muscle pain, vomiting and diarrhoea, which can initially resemble other illnesses.
The Federal Government and health authorities have urged Nigerians to follow official public health guidance, avoid misinformation and promptly seek medical advice if they develop symptoms after a possible exposure.
With no licensed, strain-specific treatment or vaccine currently available for the variant involved, early detection, supportive care, effective contact tracing and strict infection prevention remain central to efforts to contain the outbreak.